Dr. Raut is the Chief of the Division of Surgical Oncology and the inaugural Distinguished Chair for Cancer Care at Brigham and Women's Hospital. He received a BA and BS from Stanford University, MSc from University of Oxford, and MD from Harvard Medical School, where he is also a Professor of Surgery. He completed his residency in general surgery at Massachusetts General Hospital and fellowship in surgical oncology at MD Anderson Cancer Center. Dr. Raut specializes in the multidisciplinary care of patients with soft tissue sarcoma and serves as the Surgery Director for the Center for Sarcoma and Bone Oncology at Dana-Farber Brigham Cancer Center (DFBCC). His research focuses on multimodal strategies to reduce rates of local recurrence for patients with sarcoma. Dr. Raut is rated as an Elite provider by MediFind in the treatment of Angiosarcoma. His top areas of expertise are Adult Soft Tissue Sarcoma, Gastrointestinal Stromal Tumor, Angiosarcoma, Nephrectomy, and Pancreaticoduodenectomy.

Michael Cassidy is a Surgical Oncologist and a General Surgeon in Boston, Massachusetts. Dr. Cassidy has been practicing medicine for over 18 years and is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. His top areas of expertise are Angiosarcoma, Breast Cancer, Inflammatory Breast Cancer, and Paget Disease of the Breast. Dr. Cassidy is currently accepting new patients.

Katherine Thornton is an Oncologist in Boston, Massachusetts. Dr. Thornton is rated as an Elite provider by MediFind in the treatment of Angiosarcoma. Her top areas of expertise are Adult Soft Tissue Sarcoma, Angiosarcoma, Synovial Sarcoma, and Bone Tumor.

Steven Come is an Internal Medicine specialist and an Oncologist in Boston, Massachusetts. Dr. Come is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. His top areas of expertise are Breast Cancer, Angiosarcoma, Inflammatory Breast Cancer, and Paget Disease of the Breast.

Nadine Tung is an Internal Medicine specialist and an Oncologist in Boston, Massachusetts. Dr. Tung is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. Her top areas of expertise are Breast Cancer, Ovarian Cancer, BRCA Positive Breast Cancer, Salpingo-Oophorectomy, and Hormone Replacement Therapy (HRT).

Gerburg Wulf is an Internal Medicine provider in Boston, Massachusetts. Dr. Wulf is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, Triple-Negative Breast Cancer, and Hormone Replacement Therapy (HRT).

Dr. Nakhlis received her medical degree from Rush Medical College in Chicago in 1996. She subsequently completed her residency in general surgery and her breast surgery fellowship at Northwestern University in Chicago. She is an attending physician in the Brigham and Women's Hospital and Brigham and Women’s Faulkner Hospital in Boston and an assistant professor of surgery at Harvard Medical School. Her clinical research interests are focused on lobular neoplasia and other premalignant and proliferative breast lesions, and inflammatory breast cancer. Dr. Nakhlis is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. Her top areas of expertise are Inflammatory Breast Cancer, Breast Cancer, Intraductal Papilloma, Mastectomy, and Lymphadenectomy.

Dr. Lin is a medical oncologist specializing in the care of patients with all stages of breast cancer. Her research focuses upon improving the outcomes of people living with metastatic breast cancer, including a particular focus on the challenge of breast cancer brain metastases. She has led multiple clinical trials which have led to new treatment options for patients with breast cancer that has metastasized to the brain. Dr. Lin received her MD from Harvard Medical School in 1999. She completed her residency in internal medicine at Brigham and Women's Hospital and went on to complete fellowships in medical oncology and hematology at Dana-Farber. In 2005, she joined the staff of Brigham and Women's and Dana-Farber, where she is a medical oncologist and clinical investigator in the Breast Oncology Center. Dr. Lin is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. Her top areas of expertise are Inflammatory Breast Cancer, Angiosarcoma, Paget Disease of the Breast, and Breast Cancer.

Rochelle Scheib is an Oncologist in Boston, Massachusetts. Dr. Scheib is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. Her top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, Paget Disease of the Breast, and Angiosarcoma.

Dr. Partridge received her MD from Cornell University Medical College in 1995. She completed her residency in internal medicine at the Hospital of the University of Pennsylvania and went on to complete fellowships in medical oncology and hematology at DFCI, MGH and BWH. She also received an MPH from Harvard School of Public Health. She is a medical oncologist who cares for adults with breast cancer, with a particular focus on the unique needs of young patients with breast cancer. She also leads efforts to optimize cancer survivorship care and research at DFCI. She completed fellowships in Medical Oncology and Hematology at DFCI, Massachusetts General Hospital and Brigham and Women’s Hospital. Dr. Partridge is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. Her top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, HER-2 Positive Breast Cancer, Hormone Replacement Therapy (HRT), and Salpingo-Oophorectomy.

Dr. Waks received her undergraduate degree from Princeton University in 2006 and her MD degree from Harvard Medical School in 2011. She completed residency training in internal medicine at Brigham and Women's Hospital, where she subsequently served an additional year as a Chief Resident in Internal Medicine. She completed fellowship training in medical oncology at Dana-Farber/Partners CancerCare, then joined the staff of the Breast Oncology Center at Dana-Farber Cancer Institute. Dr. Waks is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. Her top areas of expertise are Breast Cancer, HER-2 Positive Breast Cancer, Inflammatory Breast Cancer, and Angiosarcoma.

Rinaa Punglia is a Radiation Oncologist in Boston, Massachusetts. Dr. Punglia is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. Her top areas of expertise are Breast Cancer, Angiosarcoma, Intraductal Papilloma, Brain Tumor, and Gastrostomy.

Priscilla Merriam is a Hematologist Oncology specialist and a Hematologist in Boston, Massachusetts. Dr. Merriam is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. Her top areas of expertise are Adult Soft Tissue Sarcoma, Liposarcoma, Alveolar Soft Part Sarcoma, and Epithelioid Sarcoma.

Dr. Mayer received her medical degree from Harvard Medical School, completed her residency in Internal Medicine at Brigham and Women's Hospital, and her fellowship in Medical Oncology at the Dana-Farber Cancer Institute. She also obtained a Masters in Public Health from the Harvard School of Public Health. She joined the staff of Dana-Farber and Brigham and Women's Hospital in 2006, where she serves as Director of Breast Cancer Clinical Research. She is a breast cancer medical oncologist and clinical investigator leading research studies focused on novel therapies for the treatment of breast cancer. Dr. Mayer is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. Her top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, Paget Disease of the Breast, and Angiosarcoma.

Dr. Tolaney is Chief of the Division of Breast Oncology at Dana-Farber Cancer Institute, and Associate Professor of Medicine at Harvard Medical School.  She is a breast medical oncologist whose research focuses on the development of novel therapies in the treatment of breast cancer.  She has been instrumental in developing several treatment approaches for breast cancer, including approaches focused on tailoring therapy for early stage HER2+ disease, use of cdk 4/6 inhibitors, antibody drug conjugates, and immunotherapy.She is a member of the National Cancer Institute Breast Cancer Steering Committee and is Vice Chair for Late-Stage Development in Breast Cancer in the Alliance for Clinical Trials in Oncology. Her research has been funded by the Breast Cancer Research Foundation and Susan G. Komen. She currently chairs multiple phase 3 trials in breast cancer and serves on several steering committees for practice-changing trials.  Her work has been published in journals such as the New England Journal of Medicine, Lancet, Lancet Oncology, Journal of Clinical Oncology, and others. She received her undergraduate degree from Princeton University in 1998 and her medical degree from UC San Francisco in 2002. She subsequently completed her residency in Internal Medicine at Johns Hopkins University, and fellowships in hematology and medical oncology at Dana-Farber Cancer Institute. She obtained a Masters in Public Health from the Harvard School of Public Health in 2007. In 2008, she joined the staff of Dana-Farber Cancer Institute and Brigham and Women's Hospital. Dr. Tolaney is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. Her top areas of expertise are Breast Cancer, HER-2 Positive Breast Cancer, Inflammatory Breast Cancer, and Triple-Negative Breast Cancer.

Dr. Jennifer Ligibel is a Professor at Harvard Medical School, the Director of the Leonard P. Zakim Center for Integrative Therapies and Healthy Living, and the Director of the Center for Faculty Well-Being at the Dana-Farber Cancer Institute. Dr. Ligibel’s research focuses on the impact of lifestyle interventions upon cancer-related outcomes in women with breast cancer. She has conducted a number of studies looking at the impact of exercise and weight loss interventions upon patients’ quality of life and symptoms after cancer diagnosis and is currently leading an NCI-funded Phase III clinical trial that will test the impact of a weight loss intervention upon the risk of disease recurrence in more than 3000 overweight and obese women with early-stage breast cancer. Dr. Ligibel was the Chair of the American Society of Clinical Oncology Subcommittee on Energy Balance, which has developed patient and physician materials to help facilitate healthy lifestyle changes after cancer diagnosis. Dr. Ligibel is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. Her top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Hormone Replacement Therapy (HRT).

Michelle Specht is a General Surgeon and a Surgical Oncologist in Boston, Massachusetts. Dr. Specht is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. Her top areas of expertise are Breast Cancer, Angiosarcoma, Inflammatory Breast Cancer, Mastectomy, and Lymphadenectomy.

Barbara Smith is a General Surgeon and a Surgical Oncologist in Boston, Massachusetts. Dr. Smith is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. Her top areas of expertise are Breast Cancer, Angiosarcoma, Paget Disease of the Breast, Inflammatory Breast Cancer, and Lymphadenectomy.

Kevin Hughes is a General Surgeon in Boston, Massachusetts. Dr. Hughes is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. His top areas of expertise are Inflammatory Breast Cancer, Angiosarcoma, Paget Disease of the Breast, Breast Cancer, and Lymphadenectomy.

Nicholas Tawa is a Surgical Oncologist in Boston, Massachusetts. Dr. Tawa is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. His top areas of expertise are Melanoma, Angiosarcoma, Inflammatory Breast Cancer, Breast Cancer, and Lymphadenectomy.